Science in 2025: the events to watch for in the coming year

Science in 2025: the events to watch for in the coming year

New and repurposed obesity drugs, daring space missions and climate-action policies are among the developments set to shape research in 2025.

By * Miryam Naddaf

A spacecraft in a laboratory, lit in blue and red.

NASA’s SPHEREx observatory will survey the whole sky during its two-year mission. Credit: BAE Systems

Weight-loss wonder drugs

Following the runaway success of ‘miracle’ drug Wegovy (semaglutide) and other GLP-1 agonists, 2025 is likely to bring results and approvals for a new wave of treatments targeting obesity. The pharmaceutical firm Eli Lilly in Indianapolis, Indiana, will wrap up a phase III trial for its oral pill orforglipron, evaluating its long-term safety in people with type 2 diabetes. The drug is easier to produce and potentially cheaper than existing treatments.


How rival weight-loss drugs fare at treating obesity, diabetes and more

Trials for Eli Lilly’s triple-action drug, retatrutide, will continue throughout 2025. In its phase II trial, retatrutide showed unprecedented efficacy, with people on the highest dose experiencing a 24.2% weight loss over 11 months (currently available drugs tend to yield around 15–20% weight loss over a similar period). Another company, Amgen in Thousand Oaks, California, is preparing a phase III trial for its drug maritide, which can be taken monthly and targets two pathways involved in blood sugar control and metabolism.

Researchers will continue to explore the potential of GLP-1 agonists to treat other illnesses, including Parkinson’s disease, Alzheimer’s and addiction.

The year could also mark a turning point in how pain is treated. US regulators are expected to complete a review of a non-opioid painkiller called suzetrigine in January. If approved, the drug, developed by Vertex Pharmaceuticals in Boston, Massachusetts, would be part of the first new class of drugs to treat acute pain in more than 20 years.

Trump takes over

Donald Trump’s return to the office of US president in January could bring sweeping changes to US science — with global ramifications. During his previous term in office, Trump pulled the United States out of the 2015 Paris climate agreement, an international commitment to limit global warming to 1.5–2 °C above pre-industrial levels. Some researchers are concerned that he might do so again, as well as rolling back climate regulations on power plants and automobiles.

Trump is also expected to introduce policies that have implications for reproductive health and medicine. His nomination of Robert Kennedy Jr — known for his scepticism towards vaccines — as health and human services secretary has been criticized by scientists. The appointment of billionaire Elon Musk to lead an advisory body named the Department of Government Efficiency could impact the budgets and workforces of science agencies. During his election campaign, Trump promised to repeal President Joe Biden’s executive order on artificial intelligence (AI), a guideline for developing AI technology safely and responsibly.

Beneath a large digital screen displaying his face, President-Elect Donald Trump walks out onto a stage.

Donald Trump will become US president for the second time on 20 January 2025.Credit: Chip Somodevilla/Getty

Pandemic prep

March 2025 will mark five years since the start of the COVID-19 pandemic, which caused millions of deaths, forced widespread lockdowns and spurred the rapid development and roll-out of vaccines.

The world is still learning how to prepare for and prevent future pandemics, and member states of the World Health Organization (WHO) missed their original June 2024 deadline to agree on a global pandemic treaty. Talks reached a deadlock over disagreements on rules for sharing samples and genomic sequences of pathogens, and for the use of technologies that can help low- and middle-income countries to produce vaccines, drugs and testing kits quickly during pandemics. Member states are now aiming to finalize the agreement text by May 2025. These efforts come at a crucial time: in August, the WHO updated its list of pathogens that could spark the next pandemic to include more than 30 microorganisms, including the viruses that cause influenza A, dengue and mpox.

Probing particles

Particle physicists are hoping to see the European Spallation Source in Lund, Sweden, begin operations in 2025, after more than a decade of construction. This colossal machine will generate neutron pulses by firing a beam of protons — accelerated to nearly the speed of light — at a heavy-metal target. Scientists will use these neutrons to probe the structure of materials.

Meanwhile, a detailed feasibility study for a proposed US$17-billion supercollider at CERN, the European particle-physics laboratory outside Geneva, Switzerland, will wrap up in 2025. The study will evaluate the cost, technical aspects and environmental impacts of building a particle accelerator 91 kilometres in circumference: the Future Circular Collider (FCC), intended to succeed the Large Hadron Collider. The report will feed into a final decision on the FCC in 2028.

Close up view of a person giving themselves an injection.

Following the success of semaglutide, several new weight-loss drugs are in development. Credit: Gavin Rodgers/pixel8000 via Alamy

Mind-reading machines

In 2025, China plans to test brain–computer interface (BCI) technologies that could compete with implants made by Elon Musk’s firm Neuralink, based in Fremont, California. China’s Ministry of Industry and Information Technology has announced plans to develop BCI devices for applications ranging from medical rehabilitation to virtual reality. One of these products is NEO, a wireless and minimally invasive BCI with eight electrodes placed over the brain’s sensorimotor cortex, designed to restore hand movement in people with paralysis. Clinical trials for NEO began in 2023, and early results showed that a participant with spinal-cord injury was able to eat, drink and grasp objects after nine months of using the BCI at home. The researchers behind NEO plan to expand to larger trials in 2025.

Exploring the Universe

In a historic first, 2024 saw a private spacecraft land successfully on the Moon. Now, 2025 looks set to be a busy year for lunar traffic. In January, Tokyo-based company ispace — which came tantalizingly close to landing its own craft in 2023 — will launch its next attempt, a mission called Venture Moon, which will carry a lander and a micro-rover. Not far behind, Intuitive Machines in Houston, Texas, will send a lander to the lunar south pole. The spacecraft will carry a NASA ice drill and mass spectrometer to analyse material beneath the lunar surface. As part of the same mission, NASA’s box-shaped spacecraft Lunar Trailblazer will orbit the Moon and map its surface water.


What Trump’s election win could mean for AI, climate and health

Two missions to study solar winds — streams of charged particles that flow from the Sun’s outer atmosphere — are set to launch in 2025. The SMILE (Solar Wind Magnetosphere Ionosphere Link Explorer) satellite, a joint project between the European Space Agency (ESA) and the Chinese Academy of Sciences, will study how solar wind interacts with Earth’s magnetic field. NASA’s PUNCH (Polarimeter to Unify the Corona and Heliosphere) mission will look deeper into the Sun’s atmosphere, capturing 3D images that will help to clear up questions about how that energy flows into the Solar System, something that has puzzled astronomers for 60 years.

Another NASA mission set to launch in 2025, the SPHEREx (Spectro-Photometer for the History of the Universe, Epoch of Reionization and Ices Explorer) observatory, will map the entire sky in 102 colours for the first time using near-infrared light. Over two years, the satellite will collect data on more than 450 million galaxies and over 100 million stars in the Milky Way to help scientists understand the origins of the Universe.

A satellite with an umbrella-like canopy orbits above a forest landscape.

ESA’s Biomass mission (artist’s impression) will use radar to study Earth’s forests from above. Credit: ESA/ATG medialab

COP turns 30

The November 2025 COP30 climate summit in Belém, Brazil, will mark 30 years of United Nations climate talks. Countries hope to finalize funding decisions left unresolved at the 2024 COP29 conference. These include how to secure $300 billion annually in climate finance pledged to support developing countries by 2035, how much will be delivered as grants, rather than loans and where the money will come from.

Negotiations for a UN plastics treaty are also set to continue, after the latest round of talks ended without a final agreement in December. The treaty seeks to establish a binding international framework to regulate plastic products.

Forests seen from space

Climate researchers will have new opportunities to study forests and natural disasters with the launch of two satellites. The NISAR (NASA-ISRO Synthetic Aperture Radar) mission, a collaboration between NASA and the Indian Space Research Organisation, will map nearly all Earth’s land- and ice-covered surface twice every 12 days. ESA’s Biomass mission, launching from Kourou, French Guiana, will use radar to measure forest biomass and study its role in the carbon cycle. Observations from these missions could feed into future discussions on commitments to end deforestation.

doi: Science in 2025: the events to watch for in the coming year

Last edited by @suen 2024-12-18T04:18:53Z

@Creative 使用中文翻譯

好的,以下是這篇文章的中文翻譯:

2025 年的科學:未來一年值得關注的事件

新的和重新設計的肥胖症藥物、大膽的太空任務和氣候行動政策是將在 2025 年塑造研究的發展方向。

作者:米里亞姆·納達夫

美國太空總署的 SPHEREx 觀測站將在其兩年任務期間對整個天空進行掃描。圖片來源:BAE Systems

減重奇效藥物

繼「奇蹟」藥物 Wegovy(司美格魯肽)和其他 GLP-1 受體促效劑 獲得巨大成功後,2025 年可能會出現針對肥胖症的新一波治療方法的結果和批准。位於印第安納州印第安納波利斯的製藥公司禮來公司將完成其口服藥物 orforglipron 的三期試驗,評估其在 2 型糖尿病患者中的長期安全性。該藥物比現有的治療方法更容易生產,而且可能更便宜。


競爭對手的減肥藥在治療肥胖症、糖尿病等方面的表現如何

禮來公司三效藥物 retatrutide 的試驗將在整個 2025 年繼續進行。在其二期試驗中,retatrutide 顯示出前所未有的療效,服用最高劑量的人在 11 個月內體重減輕了 24.2%(目前可用的藥物在類似的時間段內往往減輕約 15-20% 的體重)。另一家位於加利福尼亞州千橡市的公司安進正在準備其藥物 maritide 的三期試驗,該藥物每月服用一次,針對參與血糖控制和代謝的兩種途徑。

研究人員將繼續探索 GLP-1 受體促效劑治療其他疾病的潛力,包括帕金森病、阿茲海默症和成癮。

這一年也可能標誌著疼痛治療方式的轉捩點。美國監管機構預計將在 1 月完成對一種名為 suzetrigine 的非鴉片類止痛藥的審查。如果獲得批准,這種由位於馬薩諸塞州波士頓的 Vertex Pharmaceuticals 開發的藥物,將成為 20 多年來第一種治療急性疼痛的新類別藥物。

川普接任

唐納· 川普重返美國總統職位 將在 1 月 可能給美國科學帶來巨大變化 — 並產生全球性的影響。在他之前的任期內,川普 退出了 2015 年巴黎氣候協議,這是一項將全球暖化限制在工業化前水平以上 1.5–2 °C 的國際承諾。一些研究人員擔心他可能會再次這樣做,並撤銷對發電廠和汽車的氣候法規。

川普預計還將推出對生殖健康和醫學產生影響的政策。他提名羅伯特·肯尼迪·二世——以懷疑疫苗而聞名——擔任衛生與公共服務部長,受到了科學家的批評任命億萬富翁伊隆·馬斯克領導一個名為政府效率部的諮詢機構,可能會影響科學機構的預算和勞動力。在競選期間,川普 承諾要廢除喬·拜登總統關於人工智慧 (AI) 的行政命令,這是一項關於 安全開發人工智慧技術 和負責任的指導方針。

唐納·川普將於 2025 年 1 月 20 日第二次成為美國總統。圖片來源:Chip Somodevilla/Getty

大流行病準備

2025 年 3 月將標誌著 COVID-19 大流行病爆發五年,該大流行病造成了 數百萬人死亡,迫使大範圍封鎖,並促成了 疫苗的快速開發和推出

世界仍在學習如何為未來的大流行病做好準備和預防,世界衛生組織 (WHO) 的成員國 錯過了他們最初在 2024 年 6 月達成的截止日期,未能就全球大流行病條約達成一致意見。關於共享病原體樣本和基因組序列的規則,以及在疫情期間幫助中低收入國家快速生產疫苗、藥物和檢測試劑盒的技術的使用,會談陷入僵局。成員國現在的目標是在 2025 年 5 月前完成協定文本。這些努力正值關鍵時刻:8 月,世衛組織更新了其 可能引發下一次大流行病的病原體清單,將包括超過 30 種微生物,包括引起 甲型流感登革熱猴痘 的病毒。

探測粒子

粒子物理學家希望看到位於瑞典隆德的歐洲散裂源在經過十多年的建設後,於 2025 年開始運作。這台巨大的機器將通過將質子束加速到接近光速的速度,射向重金屬靶來產生中子脈衝。科學家將 使用這些中子來探測物質的結構

同時,一項關於在瑞士日內瓦郊外的歐洲粒子物理實驗室 CERN 擬建的 170 億美元超級對撞機的詳細可行性研究將於 2025 年結束。該研究將評估 成本、技術方面以及建造一個周長 91 公里的粒子加速器的環境影響:未來環形對撞機 (FCC),旨在接替大型強子對撞機。該報告將為 2028 年關於 FCC 的最終決定提供資訊。

繼司美格魯肽獲得成功後,幾種新的減肥藥物正在開發中。圖片來源:Gavin Rodgers/pixel8000 via Alamy

讀心機器

2025 年,中國計畫測試 腦機介面 (BCI) 技術,該技術可以與位於加州弗里蒙特的 伊隆·馬斯克公司 Neuralink 生產的植入物 競爭。中國工業和資訊化部宣布計畫開發用於從醫療復健到虛擬實境等應用領域的 BCI 裝置。其中一種產品是 NEO,這是一種無線且微創的 BCI,在腦部的感覺運動皮層上放置了八個電極,旨在恢復癱瘓患者的手部運動。NEO 的臨床試驗於 2023 年開始,早期結果顯示,一名患有脊髓損傷的參與者在家中使用 BCI 九個月後,能夠進食、飲水和抓取物體。NEO 背後的研究人員計畫在 2025 年擴大規模進行更大的試驗。

探索宇宙

2024 年,一艘 私人太空船首次成功登陸月球。現在,2025 年似乎將是月球交通繁忙的一年。1 月,總部位於東京的公司 ispace — 該公司在 2023 年差點成功登陸自己的太空船 — 將發起下一次嘗試,名為 Venture Moon 的任務,該任務將攜帶一個著陸器和一個微型探測車。緊隨其後,位於德克薩斯州休斯頓的 Intuitive Machines 將向月球南極發射一個著陸器。該太空船將攜帶美國太空總署的冰鑽和質譜儀,以分析月球表面下的物質。作為同一任務的一部分,美國太空總署的箱型太空船 Lunar Trailblazer 將繞月球運行並繪製其表面水圖。


川普當選可能對人工智慧、氣候和健康意味著什麼

兩項研究太陽風的任務將於 2025 年發射。太陽風是從太陽外層大氣流出的帶電粒子流。SMILE(太陽風磁層電離層連結探測器)衛星是歐洲太空總署 (ESA) 和中國科學院之間的聯合項目,將 研究太陽風如何與地球磁場相互作用。美國太空總署的 PUNCH(用於統一日冕和太陽圈的偏振計)任務將深入太陽大氣層,捕捉 3D 圖像,這將有助於澄清有關能量如何流入太陽系的疑問,這個問題困擾了天文學家 60 年。

美國太空總署的另一個計畫於 2025 年發射的任務 SPHEREx(宇宙歷史、再電離時代和冰層探測器的光譜光度計)觀測站,將首次使用近紅外光以 102 種顏色繪製整個天空圖。在兩年內,這顆衛星將收集超過 4.5 億個星系和銀河系中超過 1 億顆恆星的數據,以幫助科學家了解宇宙的起源。

歐洲太空總署的生物質任務(藝術家印象圖)將使用雷達從上方研究地球上的森林。圖片來源:ESA/ATG medialab

COP 滿 30 歲

2025 年 11 月在巴西貝倫舉行的 COP30 氣候峰會將標誌著聯合國氣候談判 30 週年。各國希望敲定 在 2024 年 COP29 會議上尚未解決的資金決策。其中包括如何確保每年提供 3000 億美元的氣候資金,以支持發展中國家到 2035 年的氣候融資承諾,其中多少將以贈款而非貸款的形式提供,以及這筆資金將來自何處。

在最新一輪談判 未能達成最終協議 後,關於聯合國塑膠條約的談判也將繼續進行。該條約旨在建立一個 具有約束力的國際框架,以規範塑膠產品

從太空看森林

隨著兩顆衛星的發射,氣候研究人員將有新的機會研究森林和自然災害。NISAR(美國太空總署-印度太空研究組織合成孔徑雷達)任務是美國太空總署和印度太空研究組織之間的合作,將每 12 天繪製幾乎所有地球陸地和冰層覆蓋表面的兩次地圖。歐洲太空總署的生物質任務將從法屬圭亞那的庫魯發射,將使用雷達測量森林生物量並研究其在碳循環中的作用。這些任務的觀測結果可能會為未來關於結束 毀林 承諾的討論提供資訊。

doi:Science in 2025: the events to watch for in the coming year